Skip to main
AMTX

Aemetis (AMTX) Stock Forecast & Price Target

Aemetis (AMTX) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Aemetis Inc reported significant growth in its India operations, with revenues increasing from $3 million in Q1 2025 to $12 million in Q2 2025, and further climbing to $15 million in Q3 2025, indicating a strong recovery and potential for continued growth due to new contracts expected in upcoming quarters. The company's strategic focus on converting traditional ethanol production into biorefineries underlines its commitment to renewable fuels, supporting sustainability in the energy sector. Additionally, the overall valuation of Aemetis appears attractive, suggesting potential upside based on its projected financial performance and ongoing market developments.

Bears say

Aemetis Inc. has reported weaker-than-expected revenue for both fiscal Q2 and Q3 of 2025, necessitating a downward revision of revenue estimates for 2025 to $220 million, down from $270 million, and for 2026 to $330 million, reduced from $400 million. Additionally, the company's estimated earnings per share (EPS) for 2025 has been adjusted to $(1.56) from $(1.37) and for 2026 to $(0.82) from $(0.46). The reported EPS figures were consistently below analyst expectations and consensus, highlighting ongoing financial challenges for the company.

Aemetis (AMTX) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aemetis and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aemetis (AMTX) Forecast

Analysts have given Aemetis (AMTX) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Aemetis (AMTX) has a Strong Buy consensus rating as of Jan 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aemetis (AMTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.